Erez Aminov
CEO and Director at MIRA Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: MIRA Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MIRA Pharmaceuticals Inc. September 11, 202698.9%
-
MIRA Pharmaceuticals Inc. September 11, 202598.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 22, 2026 | Telomir Pharmaceuticals Inc. | Other | +7,319,710 | $1.37 | $10,028,003 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Option exercise | +234,595 | $1.16 | $272,130 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Option exercise | +379,000 | $0.84 | $318,360 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Open-market sale | −613,595 | $2.11 | $1,294,685 |
| Oct 1, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +2,685,456 | — | — |
| Aug 29, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.37 | $85,625 |
| Mar 26, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.45 | $90,625 |
| Mar 26, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.45 | $90,625 |
| Nov 20, 2024 | MIRA Pharmaceuticals Inc. | Open-market sale | −44,590 | $1.27 | $56,629 |
| Nov 19, 2024 | MIRA Pharmaceuticals Inc. | Open-market sale | −55,410 | $1.39 | $77,020 |
| Aug 19, 2024 | Telomir Pharmaceuticals Inc. | Open-market sale | −200 | $6.01 | $1,202 |
| Aug 19, 2024 | Telomir Pharmaceuticals Inc. | Open-market sale | −200 | $6.20 | $1,240 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +2,000 | $1.00 | $2,000 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +1,000 | $1.03 | $1,030 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +500 | $1.02 | $510 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.